HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Atarashi Selected Research

Photoallergic Dermatitis (Photoallergy)

8/2012Addition of UVA-absorber butyl methoxy dibenzoylmethane to topical ketoprofen formulation reduces ketoprofen-photoallergic reaction.
8/2007Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen.
2/2007Induction of keratinocyte apoptosis by photosensitizing chemicals plus UVA.
2/2006Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Atarashi Research Topics

Disease

4Photoallergic Dermatitis (Photoallergy)
08/2012 - 02/2006
2Infections
01/2022 - 10/2020
2Tuberculosis (Tuberculoses)
01/2022 - 10/2020
2Contact Dermatitis (Eczema, Contact)
03/2009 - 03/2009
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Thymoma (Thymic Carcinoma)
01/2021
1Necrosis
02/2007

Drug/Important Bio-Agent (IBA)

4Ketoprofen (Orudis)FDA LinkGeneric
08/2012 - 02/2006
2InterferonsIBA
01/2022 - 10/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Tuberculin (PPD)IBA
01/2022
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2021
1HaptensIBA
03/2009
1Picryl Chloride (Trinitrochlorobenzene)IBA
03/2009
1Caspase 3 (Caspase-3)IBA
02/2007
16-methylcoumarinIBA
02/2007
1sparfloxacin (AT 4140)FDA Link
02/2007
1Bithionol (Bitin)IBA
02/2007
1Chlorpromazine (Thorazine)FDA Link
02/2007
1Dihydrotachysterol (AT 10)IBA
02/2007
1Diphenhydramine (Benadryl)FDA LinkGeneric
02/2007
1Pharmaceutical PreparationsIBA
02/2007
1Methoxsalen (Oxsoralen)FDA Link
02/2007
1Enoxacin (AT 2266)FDA Link
02/2007
1Annexin A5IBA
02/2007
13,3',4',5-tetrachlorosalicylanilideIBA
02/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2021